Dexcom and Apple Watch Team Up to Empower Aussies Living with Diabetes

Australians living with diabetes can now use their Apple Watch to monitor glucose levels and receive alerts through a new integration with the Dexcom G7 Continuous Glucose Monitoring (CGM) system
Dexcom G7 wearers can see their levels in real time on their Apple Watch^‡, without carrying a smartphone or receiver^†
The condition is the 21st-century epidemic and the biggest challenge confronting Australia’s healthcare system. Almost 1.9 million Aussies are living with diabetes, and more than 300 people are diagnosed every day, equivalent to one person every five minutes¹

^{DexCom, Inc. (Nasdaq: DXCM), the global leader in real-time continuous glucose monitoring for people living with diabetes, today announced that the Dexcom G7 Continuous Glucose Monitoring (CGM) System now syncs directly with Apple Watch‡ to make it easier for people to monitor their glucose levels on the go.}

^{Dexcom G7 is Australia’s most connected CGM§, making it seamless for people living with diabetes to manage their glucose levels across various smart devices†, health apps, and insulin delivery devices. It is the only CGM that connects through the internet directly to Apple Watch‡ without the need to have a smartphone† nearby.}

^{The Dexcom G7 is an all-in-one wearable device that warms up faster than any other CGM on the market ||, sending real-time glucose readings automatically to a compatible smart device† or receiver, with no fingerpricks* or manual scanning required. The Apple Watch ‡ integration allows you to receive alerts and check glucose levels in real-time, without the need to carry a smartphone† or receiver.}

“The launch of the Dexcom G7 integration with Apple Watch marks an exciting step forward for Aussies living with diabetes,” said Samy Saad, Senior Managing Director, Dexcom Australia and New Zealand. “This milestone with leading smartwatch technology brings greater convenience, discretion, and flexibility to support people in managing their glucose levels.”

Beyond Apple Watch compatibility, the Dexcom G7 connects with certain compatible insulin delivery systems such as the t:slim X2 insulin pump, giving Australians living with diabetes even more peace of mind.

It’s reported that diabetes is a 21st-century epidemic and the biggest challenge confronting Australia’s health system. It is the fastest-growing chronic condition in Australia, outpacing both heart disease and cancer. Currently, almost 1.9 million Australians live with diabetes and more than 300 new cases develop every day, which is equivalent to one person every five minutes.¹

For further information about the Dexcom G7 visit dexcom.com/en-AU/dexcom-g7-cgm-system.

About DexCom, Inc.

Dexcom empowers people to take control of their health through innovative biosensing technology. Founded in 1999, Dexcom has pioneered and set the standard in glucose biosensing for more than 25 years. Its technology has transformed how people manage diabetes, track their glucose and understand overall metabolic health, helping users feel more in control and live more confidently. 

Dexcom. Discover what you’re made of. For more information, visit www.dexcom.com. 

ALWAYS READ THE LABEL AND FOLLOW THE DIRECTIONS FOR USE. Read the warnings available on dexcom.com/downloadsandguides or amsldiabetes.com.au/resources before purchasing. Consult your healthcare professional to see if this product is right for you.

Dexcom G7 is a continuous glucose monitoring system indicated for the management of (type 1, type 2, gestational) diabetes in people age 2 years and older where self-monitoring of blood glucose (SMBG) is indicated.

The t:slim X2 insulin pump is a portable insulin infusion pump, including sterile cartridge, that delivers insulin subcutaneously through a disposable infusion set.

* If your glucose alerts and readings from Dexcom G7 do not match symptoms or expectations, use a blood glucose meter to make diabetes treatment decisions. †Smartphone sold separately. For a list of compatible devices, visit www.dexcom.com/compatibility. ‡ Compatible smartphone is required to pair a new Dexcom G7 sensor with a compatible Apple Watch. To use Share/Follow the smartphone must be within 10 meters of the Dexcom G7. § Not all connections are available in Australia. To learn more about insulin pump integrations and compatibility with Dexcom CGM Systems, visit dexcom.com/compatibility. || Dexcom G7 can complete warmup within 30 minutes, whereas other CGM brands require up to an hour or longer.

References: 1. Diabetes Australia. Diabetes in Australia. Accessible at www.diabetesaustralia.com.au/about-diabetes/diabetes-in-australia

Dexcom, Dexcom Clarity, Dexcom Follow, Dexcom G6, Dexcom G7, Dexcom ONE+, Dexcom Share, and any related logos and design marks are either registered trademarks or trademarks of Dexcom, Inc. in the United States and/or other countries. ©2025 Dexcom, Inc. All rights reserved.

Australasian Medical & Scientific is a Dexcom company.

MAT-8964